Acute leukemia associated with mediastinal germ cell tumor. De novo versus therapy-related leukemia.
AUTOR(ES)
Keung, Y K
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1022078Documentos Relacionados
- Genome-wide association study to identify novel loci associated with therapy-related myeloid leukemia susceptibility
- Expression profiling of CD34+ hematopoietic stem/ progenitor cells reveals distinct subtypes of therapy-related acute myeloid leukemia
- MLL is fused to CBP, a histone acetyltransferase, in therapy-related acute myeloid leukemia with a t(11;16)(q23;p13.3)
- Conditional MLL-CBP targets GMP and models therapy-related myeloproliferative disease
- MSF (MLL septin-like fusion), a fusion partner gene of MLL, in a therapy-related acute myeloid leukemia with a t(11;17)(q23;q25)